ACatechol
PrivateLast Round
Grant
Mar 1, 2024
Total Funding Raised
$1.2M
Company Overview
ACatechol operates in Healthcare & Life Sciences and is based in Vista, California. Its latest recorded funding round was a Grant round in March 2024.
ACatechol is a medtech company that develops and commercializes surface engineering solutions for medical, dental, and other industries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ACatechol Comparables
Compare ACatechol with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Silq Technologies | 82% | |
| LipoCoat | 82% | |
| Camstent | 80% |
For institutional investors. Book with your work email.
ACatechol Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2024 | ||||
| Accelerator | Aug 16, 2023 | ||||
| Grant | Mar 22, 2023 | ||||
| Grant | Aug 1, 2020 | ||||
| Seed | Feb 10, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ACatechol Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Ray C. Anderson Foundation | Accelerator |
| The Biomimicry Institute | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2024
$275K grant from the National Science Foundation.
- Aug 16, 2023
The Biomimicry Institute led the round.
For institutional investors. Book with your work email.
ACatechol Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ACatechol's valuation, stock price, and market status.
Is ACatechol a public or private company?
ACatechol is a private company.
What is the current stock price of ACatechol?
ACatechol is a private company, so its shares have no public market price. Caplight tracks ACatechol's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ACatechol worth (valuation)?
Valuation information for ACatechol is not publicly available.
Can I buy ACatechol stock?
ACatechol shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ACatechol's last funding round?
ACatechol's most recent funding round was Grant on March 1, 2024.
Who are the main investors in ACatechol?
Key investors in ACatechol include NIH RADx, The Biomimicry Institute, National Science Foundation.
Will ACatechol IPO soon?
No public IPO plans have been announced for ACatechol.
How can I track ACatechol secondary market activity?
Caplight tracks bids, offers, and trades in ACatechol's shares on secondary markets.